# TOL-3021 Starts A Phase-II Clinical Trial

**URL:** https://forum.fudiabetes.org/t/tol-3021-starts-a-phase-ii-clinical-trial/8526
**Category:** T1 Research
**Created:** [October 19, 2019, 8:24pm UTC](https://forum.fudiabetes.org/t/tol-3021-starts-a-phase-ii-clinical-trial/8526 "2019-10-19T20:24:08Z")
**Posts on this page:** 1
**Page:** 1

<div class="post-metadata">

### Author: ![joshualevy](https://yyz2.discourse-cdn.com/flex030/user_avatar/forum.fudiabetes.org/joshualevy/32/2189_2.png) [@joshualevy](https://forum.fudiabetes.org/u/joshualevy)
#### Post date: [October 19, 2019, 8:24pm UTC](https://forum.fudiabetes.org/t/tol-3021-starts-a-phase-ii-clinical-trial/8526/1 "2019-10-19T20:24:08Z")

</div>

I just wrote a new blog, which you can read here:

> **[TOL-3021 Starts A Phase-II Clinical Trial](https://cureresearch4type1diabetes.blogspot.com/2019/10/tol-3021-starts-phase-ii-clinical-trial.html)**
>
> TOL-3021 causes the body to generate proinsulin so that over time the immune system will get used to (or tolerate) it.  Proinsulin and insul...

This is the second human trial for TOL-3021.